-
Product Insights
NewGallbladder Cancer – Drugs In Development, 2024
Empower your strategies with our Gallbladder Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Gallbladder cancer symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine, and weight loss. Risk factors include overweight, age, family history, gallstones, gender, and choledochal cysts. Treatment includes surgery, chemotherapy, and radiation therapy. The Gallbladder Cancer drugs in development market research report provide comprehensive information on the therapeutics under development for Gallbladder Cancer, complete with...
-
Product Insights
NewAcute Ischemic Stroke – Drugs In Development, 2024
Empower your strategies with our Acute Ischemic Stroke – Drugs In Development, 2024 report and make more profitable business decisions. An acute ischemic stroke occurs when a clot blocks a brain blood vessel, depriving it of oxygen. Symptoms, like numbness, confusion, or difficulty speaking, arise suddenly. Immediate medical attention is crucial. Treatment focuses on restoring blood flow, often with clot-dissolving drugs or a thrombectomy. Recovery varies; rehabilitation helps regain lost abilities. Lifestyle changes and medication may prevent future strokes. Early recognition...
-
Product Insights
NewIntracerebral Hemorrhage – Drugs In Development, 2024
Empower your strategies with our Intracerebral Hemorrhage – Drugs In Development, 2024 report and make more profitable business decisions. Intracerebral hemorrhage (ICH), a devastating stroke subtype, involves the formation of a hematoma within the brain parenchyma, with or without extension into the ventricles. Accounting for 10-15% of all strokes, non-traumatic ICH is linked to high morbidity and mortality. Risk factors encompass chronic hypertension, amyloid angiopathy, anticoagulation, and vascular malformations. The resulting brain injury is categorized as primary, signifying initial damage by...
-
Product Insights
NewPleural Disease – Drugs In Development, 2024
Empower your strategies with our Pleural Disease – Drugs In Development, 2024 report and make more profitable business decisions. Pleural disorders encompass a spectrum of conditions affecting the protective tissue surrounding the lungs and lining the chest cavity. Within this category, three distinct types emerge—namely pleurisy, pleural effusion, and pneumothorax—each with diverse etiologies. Characterized by inflammation of the pleura, pleurisy stands as a primary manifestation. Conversely, pleural effusion and pneumothorax result from factors such as infection, medical conditions, or chest trauma,...
-
Product Insights
NewChordoma – Drugs In Development, 2024
Empower your strategies with our Chordoma – Drugs In Development, 2024 report and make more profitable business decisions. Chordoma is a rare type of bone cancer that occurs in the bones of the spine or the base of the skull. It begins in cells that once made up structures in the developing embryo that then developed into the disks of the spine. Most of these cells are gone by the time of birth or soon after, but sometimes a few remain...
-
Product Insights
NewMeningioma – Drugs In Development, 2024
Empower your strategies with our Meningioma – Drugs In Development, 2024 report and make more profitable business decisions. A meningioma is a type of tumor that develops from the meninges, the membrane that surrounds the brain and spinal cord. There are three layers of meninges, called the dura mater, arachnoid, and pia mater. Most meningiomas (90%) are categorized as benign tumors, with the remaining 10% being atypical or malignant. There is no obvious cause of a meningioma. However, this type of...
-
Product Insights
NewCutaneous T-Cell Lymphoma – Drugs In Development, 2024
Empower your strategies with our Cutaneous T-Cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Cutaneous T-cell lymphoma (CTCL) is a rare type of cancer that begins in white blood cells called T cells (T lymphocytes). These cells normally help body's germ-fighting immune system. In cutaneous T-cell lymphoma, the T cells develop abnormalities that make them attack the skin. Originating in T lymphocytes, it causes skin alterations like red, scaly patches or itchy plaques, progressing slowly...